French government cuts payments for “moderately useful” drugsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7396.951/b (Published 03 May 2003) Cite this as: BMJ 2003;326:951
- Alexander Dorozynski
In a decree published over the Easter holidays the French government has reduced the amount of subsidy it gives on 617 drugs it judges to be of only “moderate medical usefulness.”
These drugs, which include many of the drugs most often prescribed by general practitioners, are subsidised at the rate of 65% by the Department of Social Security's health insurance branch. As of 20 May the drugs will be subsidised at the rate of 35%. Patients—or their insurance company—will assume the balance of the cost.
The measure is expected to save about …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial